March 2008
MSI Newsletter
Volume 3, Issue 3
 

Nonfasting triglyceride levels are independently associated with incident cardiovascular events

Fasting triglyceride levels show little independent association

The importance of triglycerides in cardiovascular risk is controversial. Triglycerides are typically determined in the fasting state, yet postprandial hypertriglyceridaemia may play an important role in atherosclerosis. This study sought to determine the association of fasting versus nonfasting triglyceride levels and risk of future cardiovascular events. Controversy surrounds the role of triglycerides in cardiovascular disease, in part because the relation between the two is attenuated by adjustment for high-density lipoprotein (HDL)cholesterol, levels of which are inversely correlated with triglyceride levels. Also, triglyceride levels are usually measured in the fasting state, whereas postprandial lipids seem to play an important part in the pathogenesis of cardiovascular disease. In this study, Bansal et al assessed the association of fasting and nonfasting triglyceride levels with incident cardiovascular events in a prospective cohort of initially healthy women, independently of classic cardiac risk factors, other lipid levels, and insulin resistance markers.

Study population, design and measurements

This prospective study involved 26,509 initially healthy women participating in the US Women’s Health Study (enrolled between November 1992 and July 1995) followed up for a median 11.4 years. Blood samples collected at enrollment were used for triglyceride determination. Participants whose last meal was at least 8 hours prior to blood sample collection were taken as the fasting cohort (n=20,118), while those who had eaten within 8 hours of blood sampling constituted the nonfasting cohort (n=6,391).The main outcome measure was hazard ratios for incident cardiovascular events, which were a composite of nonfatal myocardial infarction, coronary revascularization, nonfatal ischaemic stroke, or cardiovascular death. An end points committee adjudicated all cardiovascular events, and if a participant had more than one event, only the first was used in the analysis.

Results

A total of 1,001 participants had a first cardiovascular event during a median follow-up of 11.4 years, which corresponds to an overall event rate of 3.46 per 1000 person-years of follow-up. After adjustment for age, smoking, blood pressure, and use of hormone therapy (which increases triglyceride levels by about 20%), both fasting and nonfasting triglyceride levels were strongly associated with cardiovascular events (see Figure).The association between triglyceride levels and cardiovascular events among fasting participants was substantially weakened following adjustment for total cholesterol and HDL-cholesterol, and for indicators of insulin resistance (diabetes mellitus, body mass index, C-reactive protein). In contrast, the strong association with cardiovascular events in the nonfasting participants persisted after full adjustment. Secondary analyses stratified by time since the participants’ last meal showed that the strongest association of cardiovascular events was with triglyceride levels measured 2 to 4 hours postprandially (fully adjusted hazard ratio [95% confidence interval] for highest versus lowest tertiles of levels = 4.48 [1.98-10.15] [P<0.001 for trend]). Longer periods of fasting attenuated this association. Because of data suggesting that adjustment for HDL-cholesterol substantially alters the relation between cardiovascular disease and triglycerides, the authors repeated their analyses stratified by HDL-cholesterol level. Only high nonfasting triglyceride levels were independently associated with events in participants with normal HDL-cholesterol (50 mg/dL). High levels of triglycerides increased risk in both fasting and nonfasting women with HDL-cholesterol <50 mg/dL, but the magnitude of the effect was greater in the nonfasting group.

Conclusion

The authors argue that their data provides support for the broad hypothesis that atherosclerosis is at least partly a “postprandial phenomenon”. In addition to this putative atherogenic effect of postprandial lipids, high triglyceride levels are also a manifestation of the constellation of metabolic derangements associated with insulin resistance and the metabolic syndrome.The data reported in this article are consonant with prior cross-sectional studies correlating postprandial levels with severity of carotid atherosclerosis, and with case-control studies that indicate higher postprandial levels among individuals with coronary heart disease. The authors believe that fasting levels of triglycerides may not be the best marker for atherogenicity associated with hypertriglyceridaemia, and suggest that nonfasting levels constitute a more reliable criterion for participant inclusion in future trials of triglyceride-lowering agents.

Figure. Association of triglyceride levels with cardiovascular event rate.

A: In fasting participants (n=20,118)
B: in nonfasting participants (n=6,391)

Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16.

View Abstract

Featured Upcoming Congresses
(April - June 2008)

American College of Cardiology - 57th Annual Scientific Session
Date:
  March 29 - April 1, 2008
Location:
  Chicago, Illinois, USA
Website:
  Click here

7th International Diabetes Western Pacific Region Congress
Date:
  March 30 - April 3, 2008
Location:
  Wellington, New Zealand
Website:
  Click here

1st International Congress on Prehypertension & Cardiometabolic Risk
Date:
  April 2-5, 2008
Location:
  Prague, Czech Republic
Email:
  prehypertension@kenes.com

16th European Congress on Obesity (ECO)
Date:
  May 14-17, 2008
Location:
  Geneva, Switzerland
Website:
  Click here

AACE 17th Annual Meeting and Clinical Congress
Date:
  May 14-18, 2008
Location:
  Orlando, Florida, USA
Website:
  Click here

5th World Congress on Prevention of Diabetes and its Complications
Date:
  June 1-4, 2008
Location:
  Helsinki, Finland
Website:
  Click here


Featured Ongoing Trial


Hypoglycaemic Agents
Trial - Heart 2D

Heart2D
Hyperglycaemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in
Patients with Type 2 Diabetes

Combined Study Outcomes:
CV death, nonfatal stroke, hospitalization for acute coronary syndromes, and coronary revascularization procedures planned after randomization.

Expected Total Enrollment:
1355 type 2 diabetes patients with a recent acute myocardial infarction.

Comparisons:
Either premeal insulin lispro and, if necessary, NPH insulin at bedtime or basal insulin or pre-mixed intermediate-acting insulin (insulin lispro; NPH human insulin; biphasic human insulin 30/70; insulin glargine.)

Study Design:
Randomized, open label, active control, parallel assignment.

> View all landmark studies and clinical trials





Framingham Risk Assessment Tool
Estimates 10-year risk of developing hard CHD
> View Tool

Procam Risk Calculator
Estimates your risk of a heart attack (myocardial infarction) within the next 10 years based upon data of the PROCAM Study
> View Calculator


SCORE
(European High Risk Chart)

Estimates 10 year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol and smoking status.
> View Chart

UKPDS Risk Engine
The UKPDS Risk Engine is a type 2 diabetes specific risk calculator based on 53,000 patients years of data from the UK Prospective Diabetes Study, which also provides an approximate 'margin of error' for each estimate.
> View Risk Engine

 
Mission of the Metabolic
Syndrome Institute

Created in 2003, the Metabolic Syndrome Institute is an independent and not for profit association. Its members are international experts in lipid metabolism, diabetes, heart disease, endocrinology obesity, genetics, epidemiology, basic research and health economics. Being the first association totally devoted to the dissemination of knowledge about the metabolic syndrome, the Metabolic Syndrome Institute will provide an international multidisciplinary approach to a worldwide public health problem.

 
Contact Metabolic Syndrome Institute
212, avenue Paul Doumer
92500 Rueil-Malmaison Cedex
FRANCE
Phone: (33) 1 41 42 20 35
Fax: (33) 1 41 42 20 01
Email:

contact@metabolic-syndrome-institute.org
Website:
http://www.metabolic- syndrome-institute.org

Metabolic Syndrome
in the News

HIGHLIGHTS FROM FEBRUARY


A large breast size in late adolescence as a predictor of type 2 diabetes in middle-aged women
(Posted: February 29, 2008)

Moderate alcohol consumption associated with a lower prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke and peripheral arterial disease
(Posted: February 28, 2008)

Duration of lactation associated with lower prevalence of metabolic syndrome in midlife, parous women
(Posted: February 27, 2008)

Lifestyle intervention may reduce risk of cardiovascular diseases in the long run
(Posted: February 26, 2008)

Benefits of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in subjects with metabolic syndrome
(Posted: February 25, 2008)

Significant familial resemblance as regards metabolic syndrome and its components in a large Chinese population
(Posted: February 22, 2008)

Seasonal changes in mood and behaviour linked to metabolic syndrome
(Posted: February 21, 2008)

Whilst pericardial fat is correlated with multiple measures of adiposity and cardiovascular disease risk factors, visceral abdominal fat appears to be a stronger correlate of most metabolic risk factors
(Posted: February 20, 2008)

Cardiovascular risk factors are common in patients with young-onset diabetes regardless of autoimmunity status
(Posted: February 19, 2008)

Need for a unified definition of the metabolic syndrome in children and adolescents
(Posted: February 18, 2008)

Increased risk of myocardial infarction in hypertensive South Asians living in the United Kingdom as a result of a higher prevalence of diabetes mellitus
(Posted: February 15, 2008)

Diabetic retinopathy associated with an increased incidence of cardiovascular events in patients with type 2 diabetes
(Posted: February 14, 2008)

Presence of metabolic syndrome (NCEP and revised-NCEP) associated with increased risk of cardiovascular events and all-cause mortality in subjects with various manifestations of atherosclerosis
(Posted: February 13, 2008)

Increases in causal blood glucose, even within the normal range, predict cardiovascular disease mortality
(Posted: February 12, 2008)

Adiponectin as a powerful maker of diabetes risk, even after adjustment for weight
(Posted: February 11, 2008)

Hypovitaminosis D and its relationship with adiposity, insulin sensitivity, ethnicity and season in obese children and adolescents
(Posted: February 8, 2008)

Alcohol intake may attenuate the relation between saturated fat and subclinical atherosclerosis
(Posted: February 7, 2008)

Subpopulation of triglyceride-rich lipoproteins and HDL lipoproteins as better predictors of coronary heart disease than triglycerides and HDL-cholesterol concentrations in postmenopausal women
(Posted: February 6, 2008)

Potential long-term effects of the very-low-carbohydrate high-fat diet are a matter of concern
(Posted: February 5, 2008)

Impaired fasting glucose definitions shown to be associated with increased cardiovascular risk in women but not in men
(Posted: February 4, 2008)

Inverse relationship between HDL-cholesterol and coronary risk even among patients with low LDL-cholesterol
(Posted: February 1, 2008)

     
Coordinated by Dr. Scott Grundy, Past-President of the IAS